Home
Categories
Ingredients
Analysis
Manufacturing
Finance
Regulatory
Drug Delivery
Research & Development
Sustainability
Pharma 5.0
Company News
Events
Directory
Search
Close search
Home
Company
Phylogica
Phylogica
Activities:
Ingredients
Research & Development
X
LinkedIn
Trending Articles
Innovation in generics: increased efficiency through peptide API synthesis expertise
Leading Swiss pharmaceutical company Bachem explains the benefits of converging LPPS in the manufacturing of gonadotropin-releasing hormone (GnRH) analogues
COVID-19 still a significant risk for the immunocompromised, study finds
AstraZeneca's INFORM study highlights the persistent danger of COVID-19 for the immunocompromised despite the vaccination scheme
US court lifts modified consent decree on Xellia’s Cleveland facility
The Modified Consent Decree imposed on Xellia's Cleveland facility in 2016 has been vacated, receiving a VAI
Lonza's AI-enabled small molecule development tool launches
The company's AI-enabled Route Scouting Service will optimise synthetic route identification when identifying novel APIs
Autoscribe Informatics’ new Australia office supports business growth
The company's move to West Lakes Adelaide expands its ability to service the Asia Pacific region in digitalising laboratory information
Upcoming event
ASGCT Annual Meeting 2024
7-11 May, 2024 | Meeting | Portland, OR
See all
Related Content
Research & Development
Phylogica signs deal with UK biotech to identify and develop cancer drugs
Takes a 7.5% stake in PhoreMost, based in Cambridge
Research & Development
Phylogica enters into research and licensing agreement with Genentech
Perth, Australia-based company will receive an upfront payment of US$500,000
Research & Development
Phylogica expands peptide drug conjugates pact with Janssen
Australian firm has received an undisclosed payment to fund additional research
Research & Development
Phylogica enters peptide agreement with Janssen Biotech
To identify cell-penetrating Phylomer peptides
Research & Development
Phylogica forms target discovery spin-off
Sets up new venture called Phenomica with University of Cambridge in the UK
Research & Development
Phylogica completes first stage of collaboration with Roche
Receives undisclosed milestone payment
Research & Development
Phylogica to collaborate with Pfizer
To discover novel peptide-based vaccines
Subscribe now